Company intelligence / Profile preview

Jericho Sciences

Durham, North Carolina, United Statesjerichosciences.com ↗

Ownership: Private
Employees: ~1
Development stage: Other

Overview

Jericho Sciences has developed a small molecule antiviral lead candidate that demonstrated sustained virus suppression in preclinical models of FIV/cat as an analog for HIV. The company received NIH SBIR grants to further develop both its therapeutic and diagnostic platforms. A U.S. patent was issued covering methods to activate latently-infected cells from small blood volumes without prior cell isolation, supporting their personalized diagnostics approach. No published human clinical trial results are available.

Therapeutic areas: Infectious Diseases
Modalities: Small moleculeDiagnostic assay
Industry: Biotech

Drug pipeline

1 asset

FX101

Preclinical

Partnerships

UNC/NCSU Joint Biomedical Engineering Department internship programcollaboration with UNC CFAR VIM on research poster presentations and technology development

Beyond the preview

Go deeper on Jericho Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jericho Sciences.

Explore the full profile